Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
CAFC Agrees Kubin Claims Are Obvious;Mixed Decision from CAFC on Changes Desired by PTO;Options for Patenting Genetic Tests;Roche Sues Mylan over Capecitabine Plans;Human Gene Patents Not as Toxic as Predicted;Pacific Biosciences Named Senior Party in Dispute with Life Technologies;Novocell Receives U.S. Endoderm Patent;Helicos to Appeal EPO Maintenance of Illumina Patent;Alnylam to Receive RNA Interference Patent;Mixed Decision in Compact Disk Dispute at ITC;Patent Misuse Defense Is One Issue